Allergan

Former CooperVision Leader Tom Bender Joins MediPrint Ophthalmics as Strategic Advisor

Retrieved on: 
Tuesday, February 13, 2024
Research, FDA, Clinical Trials, Health Technology, Biotechnology, General Health, Pharmaceutical, Health, Optical, Science, Ocular hypertension, CooperVision, 3D, The Cooper Companies, Retirement, Contact, Allergan, Patient, Management

MediPrint Ophthalmics , a clinical stage ophthalmic company focused on transforming the delivery of ophthalmic pharmaceuticals, today proudly announced the appointment of Thomas Bender as a strategic advisor.

Key Points: 
  • MediPrint Ophthalmics , a clinical stage ophthalmic company focused on transforming the delivery of ophthalmic pharmaceuticals, today proudly announced the appointment of Thomas Bender as a strategic advisor.
  • Mr. Praful Doshi, CEO and Founder of MediPrint Ophthalmics , welcomed the new addition, stating, "Tom Bender's appointment marks a defining moment for our company.
  • His exceptional leadership transformed CooperVision into a global market leader, and we anticipate his insights will greatly progress our strategic initiatives and operational excellence."
  • Mr. Bender served as CEO of CooperVision from 1991 until his retirement as CEO in 2007, continuing as Chairman until 2021.

Body Fat Reduction Global Market Report 2024: Asia-Pacific Emerge as Fastest-Growing Region - Long-term Forecasts to 2028 and 2033 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 31, 2024
Biotechnology, Pharmaceutical, Health, Surgery, Growth, Research, Obesity, Prevalence, Strategic planning, Allergan, Dietary supplement

The "Body Fat Reduction Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Body Fat Reduction Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.
  • The global market for body fat reduction is undergoing significant growth, with the latest industry analysis revealing a surge in demand for both surgical and non-surgical fat reduction techniques.
  • The report delineates an array of factors propelling the growth of the body fat reduction market.
  • This market analysis emphasizes the incremental growth within the body fat reduction industry, shedding light on opportunities, market trends, advancements, and regional hotspots.

Sirona Biochem Corporate Update January 2024

Retrieved on: 
Wednesday, January 24, 2024
IP, Cellulite, Communication, OTC, TSX, Allergan, Sirona, Safety, Intellectual property, SGLT, Ageing, Cosmeceutical, Pharmaceutical industry

VANCOUVER, British Columbia, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) provides the following update:

Key Points: 
  • VANCOUVER, British Columbia, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) provides the following update:
    We are pleased to provide an update on our recent milestones and strategic decisions shaping Sirona Biochem's path forward.
  • Sirona Biochem will maintain majority ownership in the subsidiary.
  • Envisioning beyond a single product, Sirona Biochem sees a future of diversified offerings with multiple products utilizing GlycoProteMim.
  • By pursuing a quicker route to profitability, we reduce reliance on recurrent financing, ensuring stability and a sustainable growth trajectory for Sirona Biochem and its subsidiaries.

BodyLase® Med Spa Ends 2023 Among Top 50 Allergan Providers

Retrieved on: 
Thursday, January 18, 2024
Diamond, Triangle, Beauty, Day spa, Elective surgery, Female, WRAL, News, Allergan, Lip, Fat removal procedures, Beauty salon

RALEIGH, N.C., Jan. 18, 2024 /PRNewswire/ -- BodyLase® Med Spa , with locations in Raleigh and Cary, ended 2023 being named a Top 50 national provider by Allergan the makers of BOTOX® , Juvederm , CoolSculpting , and more.

Key Points: 
  • RALEIGH, N.C., Jan. 18, 2024 /PRNewswire/ -- BodyLase® Med Spa , with locations in Raleigh and Cary, ended 2023 being named a Top 50 national provider by Allergan the makers of BOTOX® , Juvederm , CoolSculpting , and more.
  • Trailblazing in beauty and aesthetics since 2002, BodyLase, under female leadership, continues to help Triangle clients look and feel their best.
  • The highly-trained providers at BodyLase specialize in designing personalized aesthetic plans that address each client's unique goals.
  • BodyLase is also proud to be voted Raleigh's Best med spa by the News & Observer for 2022 and 2023, WRAL's Voter's Choice Winner for Laser/Skin Care in 2023, ranks among America's fastest-growing companies on the 2023 Inc. 5000 list, is in the Top 10% of Morpheus8 providers in North America for 2023, and is a Black Diamond provider with Hydrafacial.

miraDry® Appoints Medical Aesthetic Leaders Amber Edwards as Chair and Robert Catlin as New Chief Executive Officer

Retrieved on: 
Tuesday, January 16, 2024
Dermatology, Patient, Hyperhidrosis, Merz, Culture, SVP, Amber, Chair, Allergan, Perspiration, FDA, Capital, Bausch Health, Endo International, Growth, Management

NEWPORT BEACH, Calif., Jan. 16, 2024 /PRNewswire/ -- miraDry, the global medical device leader in underarm sweat and odor treatment, announces Amber Edwards as newly appointed Chair and Robert Catlin, former SVP and General Manager of Endo Aesthetics, as Chief Executive Officer. Arash Khazei will step down as Chief Executive Officer, continuing in the near term as a strategic advisor to the company. Together Ms. Edwards and Mr. Catlin bring a wealth of experience in global commercial excellence, positioning miraDry for significant expansion.

Key Points: 
  • NEWPORT BEACH, Calif., Jan. 16, 2024 /PRNewswire/ -- miraDry, the global medical device leader in underarm sweat and odor treatment, announces Amber Edwards as newly appointed Chair and Robert Catlin, former SVP and General Manager of Endo Aesthetics, as Chief Executive Officer.
  • Arash Khazei will step down as Chief Executive Officer, continuing in the near term as a strategic advisor to the company.
  • Together Ms. Edwards and Mr. Catlin bring a wealth of experience in global commercial excellence, positioning miraDry for significant expansion.
  • "We are thrilled to have Rob Catlin join this dynamic team bringing broad commercial leadership experience in dermatologic and aesthetic categories.

miraDry® Appoints Medical Aesthetic Leaders Amber Edwards as Chair and Robert Catlin as New Chief Executive Officer

Retrieved on: 
Tuesday, January 16, 2024
Dermatology, Patient, Hyperhidrosis, Merz, Culture, SVP, Amber, Chair, Allergan, Perspiration, FDA, Capital, Bausch Health, Endo International, Growth, Management

NEWPORT BEACH, Calif., Jan. 16, 2024 /PRNewswire/ -- miraDry, the global medical device leader in underarm sweat and odor treatment, announces Amber Edwards as newly appointed Chair and Robert Catlin, former SVP and General Manager of Endo Aesthetics, as Chief Executive Officer. Arash Khazei will step down as Chief Executive Officer, continuing in the near term as a strategic advisor to the company. Together Ms. Edwards and Mr. Catlin bring a wealth of experience in global commercial excellence, positioning miraDry for significant expansion.

Key Points: 
  • NEWPORT BEACH, Calif., Jan. 16, 2024 /PRNewswire/ -- miraDry, the global medical device leader in underarm sweat and odor treatment, announces Amber Edwards as newly appointed Chair and Robert Catlin, former SVP and General Manager of Endo Aesthetics, as Chief Executive Officer.
  • Arash Khazei will step down as Chief Executive Officer, continuing in the near term as a strategic advisor to the company.
  • Together Ms. Edwards and Mr. Catlin bring a wealth of experience in global commercial excellence, positioning miraDry for significant expansion.
  • "We are thrilled to have Rob Catlin join this dynamic team bringing broad commercial leadership experience in dermatologic and aesthetic categories.

AMP Welcomes H-MD Medical Spa of Oklahoma, Demonstrating Continued Growth in the Aesthetics Industry

Retrieved on: 
Thursday, January 11, 2024
Trailblazer, Laser, Partnership, Attention, AMP, Allergan, Name, Specialization, MD, Johns Hopkins, Health

DALLAS, Jan. 11, 2024 /PRNewswire/ -- Advanced Medaesthetic Partners (AMP), a leading network in the aesthetic and cosmetic medicine industry, proudly announces its partnership with H-MD Medical Spa, a state-of-the-art provider of aesthetic treatments in Oklahoma City. This move marks an exciting milestone for AMP, representing expansion into its fifteenth state.

Key Points: 
  • By joining this esteemed consortium, H-MD Medical Spa now stands alongside some of the most distinguished and trusted names in the aesthetics field.
  • "We are thrilled and honored to be embraced as a member of this esteemed group of aesthetic practices," said Jennie Hunnewell, MD, Founder and CEO of H-MD Medical Spa.
  • "We are delighted to welcome H-MD Medical Spa into our exclusive family of practices," stated Nicole Chiaramonte, CEO of AMP .
  • The collaboration with AMP will provide H-MD Medical Spa access to valuable resources, cutting-edge research, and collaboration opportunities with other industry leaders.

Dermal Fillers Market Size to Hit USD 8.8 Billion by 2035 | Exclusive Report by Roots Analysis

Retrieved on: 
Thursday, January 11, 2024
Artificial intelligence, Swelling, Dermatology, Research, Hospital, Bruise, Face, Partnership, MENA, Risk, Skin, Filler (linguistics), Allergan, Muscle weakness, Virtual reality, Ageing, Growth, Beauty salon

LONDON, Jan. 11, 2024 /PRNewswire/ -- The global dermal fillers market is estimated to be worth USD 3.1 billion in 2023 and is anticipated to reach USD 8.8 billion by 2035. It is expected to grow at a compounded annual growth rate (CAGR) of 9.18% during the forecast period from 2023 to 2035.

Key Points: 
  • Though the dermal fillers market is expanding positively across the globe, several restraints may impact the growth.
  • The dermal fillers market is witnessing several collaborations between key players to enhance the development of advanced dermal filler formulations.
  • Based on gender, the dermal fillers market is led by females, capturing 90% of the market share in 2023.
  • The dermal fillers market report also includes detailed profiles of key players (listed below) that provide innovative vial solutions.

Dermal Fillers Market Size to Hit USD 8.8 Billion by 2035 | Exclusive Report by Roots Analysis

Retrieved on: 
Thursday, January 11, 2024
Artificial intelligence, Swelling, Dermatology, Research, Hospital, Bruise, Face, Partnership, MENA, Risk, Skin, Filler (linguistics), Allergan, Muscle weakness, Virtual reality, Ageing, Growth, Beauty salon

LONDON, Jan. 11, 2024 /PRNewswire/ -- The global dermal fillers market is estimated to be worth USD 3.1 billion in 2023 and is anticipated to reach USD 8.8 billion by 2035. It is expected to grow at a compounded annual growth rate (CAGR) of 9.18% during the forecast period from 2023 to 2035.

Key Points: 
  • Though the dermal fillers market is expanding positively across the globe, several restraints may impact the growth.
  • The dermal fillers market is witnessing several collaborations between key players to enhance the development of advanced dermal filler formulations.
  • Based on gender, the dermal fillers market is led by females, capturing 90% of the market share in 2023.
  • The dermal fillers market report also includes detailed profiles of key players (listed below) that provide innovative vial solutions.

PatientFi Appoints Ray Bassi as New Senior Vice President, Sales

Retrieved on: 
Monday, January 8, 2024
Practice Management, Payments, Finance, Health, Health Technology, Professional Services, Technology, Fintech, Entrepreneurship, Dermatology, AB toxin, Allergan, Growth, Patient, Deoxycholic acid, Hyperhidrosis, AbbVie, Senior, Pharmaceutical industry

PatientFi , the company which offers healthcare practices payment plans and membership solutions to increase affordability for elective procedures, today announced that aesthetic industry veteran Ray Bassi has joined the company as Senior Vice President, Sales.

Key Points: 
  • PatientFi , the company which offers healthcare practices payment plans and membership solutions to increase affordability for elective procedures, today announced that aesthetic industry veteran Ray Bassi has joined the company as Senior Vice President, Sales.
  • Prior to leaving Allergan Aesthetics, Ray served as Vice President of Sales, overseeing the U.S. injectable portfolio sales team, comprised of 300+ employees.
  • Ray joined Dermira, after leaving Allergan, as Vice President of Sales where he helped launch QBREXZA, a topical treatment for axillary hyperhidrosis.
  • Prior to joining PatientFi, Ray served as Vice President of Sales for DermTech, a skin genomics company, where he led the expansion of the sales organization.